Cargando…
Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)
The Monogenic Network of the Global Parkinson’s Genetics Program (GP2) aims to create an efficient infrastructure to accelerate the identification of novel genetic causes of Parkinson’s disease (PD) and to improve our understanding of already identified genetic causes, such as reduced penetrance and...
Autores principales: | Lange, Lara M., Avenali, Micol, Ellis, Melina, Illarionova, Anastasia, Keller Sarmiento, Ignacio J., Tan, Ai-Huey, Madoev, Harutyun, Galandra, Caterina, Junker, Johanna, Roopnarain, Karisha, Solle, Justin, Wegel, Claire, Fang, Zih-Hua, Heutink, Peter, Kumar, Kishore R., Lim, Shen-Yang, Valente, Enza Maria, Nalls, Mike, Blauwendraat, Cornelis, Singleton, Andrew, Mencacci, Niccolo, Lohmann, Katja, Klein, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300084/ https://www.ncbi.nlm.nih.gov/pubmed/37369645 http://dx.doi.org/10.1038/s41531-023-00526-9 |
Ejemplares similares
-
Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)
por: Lange, Lara M., et al.
Publicado: (2023) -
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
por: Towns, Clodagh, et al.
Publicado: (2023) -
Mendelian Randomization — the Key to Understanding Aspects of Parkinson's Disease Causation?
por: Noyce, Alastair J., et al.
Publicado: (2015) -
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
por: Avenali, Micol, et al.
Publicado: (2020) -
Genetic Testing for
GBA
and
LRRK2
Mutations: Is it Time for Routine Use?
por: Roopnarain, Karisha, et al.
Publicado: (2023)